PEDIATRICS Vol. 62 No. 6 December 1978, pp. 1196-1201
This Article
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bierich, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bierich, J. R.

Estrogen Treatment of Girls With Constitutional Tall Stature

Jürgen R. Bierich M.D.1

1 Universitäts-Kinderklinik, Tübingen, Federal Republic of Germany

We define "tall stature" as a body height 2 SD or more above the mean of the population. The mean height for adult women in our country is 166 cm; the 97th percentile is 179 cm.

Up to 1976, we treated tall girls if their expected definite height surpassed 180 cm. Under the impression of the publications of Ziel and Finkle1 and Smith and co-workers,2 at the end of last year we decided to restrict the indication for estrogen treatment to girls with a growth prognosis above 183 cm. The prognosis has been made with the Greulich-Pyle Atlas and the tables of Bayley and Pinneau. Bone age was always determined independently by two experts.

This report is based on the therapeutic results in 41 girls aged 10 to 15 years whose treatment now is finished. At the start, their average age was 13 years and 2 months. In half of the girls, menarche had already occurred; their mean age was 13frac12 years. In the other half, this had not been the case; their mean age was 12 years and 9 months. Mean midparents' height was 177 cm for the whole series. This is considerably higher than the average for the population, which in Great Britain is 168 cm, according to Tanner et al.3

METHODS

Therapy was performed with conjugated natural estrogens (Presomnen [Germany]; Premarin, comparable US product). The daily dose was six 1.25-mg tablets, ie, 7.5 mg/day. The estrogens were given continuously without any interruption. To obtain menstruation-like bleedings, the girls took an oral estrogen for five days in the fourth week, at first megestrol, later dydrogesterone.




This article has been cited by other articles:


Home page
 Arch Pediatr Adolesc MedHome page
J. M. Lee and J. D. Howell
Tall girls: the social shaping of a medical therapy.
Arch Pediatr Adolesc Med, October 1, 2006; 160(10): 1035 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. L. S. Drop, W. J. de Waal, and S. M. P. F. de Muinck Keizer-Schrama
Sex Steroid Treatment of Constitutionally Tall Stature
Endocr. Rev., October 1, 1998; 19(5): 540 - 558.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child.Home page
E Weimann, S Bergmann, and H J Böhles
Oestrogen treatment of constitutional tall stature: a risk-benefit ratio
Arch. Dis. Child., February 1, 1998; 78(2): 148 - 151.
[Abstract] [Full Text]

Home page
 CLIN PEDIATRHome page
J. F. Sotos
Overgrowth
Clinical Pediatrics, October 1, 1996; 35(10): 515 - 529.
[PDF]